Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel · Delayed Price · Currency is ILS · Price in ILA 41.10
+3.80 (10.19%)
Sep 11, 2025, 5:26 PM IDT
TLV:CBI Revenue
Clal Biotechnology Industries had revenue of 91.00K ILS in the twelve months ending June 30, 2025, down -93.19% year-over-year.
Revenue (ttm)
91.00K
Revenue Growth
-93.19%
P/S Ratio
737.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
67.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 104.00K | -266.00K | -71.89% |
| Dec 31, 2022 | 370.00K | 146.00K | 65.18% |
| Dec 31, 2021 | 224.00K | 18.00K | 8.74% |
| Dec 31, 2020 | 206.00K | -113.09M | -99.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 56.02B |
| Danel (Adir Yeoshua) | 2.84B |
| Kamada | 571.15M |
| BrainsWay | 155.27M |
| SofWave Medical | 234.12M |
| Bait Bakfar | 106.25M |
| Novolog (Pharm-Up 1966) | 2.04B |
| Ilex Medical | 922.54M |